fibrinogen has been researched along with Hemorrhagic Thrombocythemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamiec, R; Gacka, M; Jakobsche-Policht, U; Kuliszkiewicz-Janus, M; Kwiatkowski, J; Małecki, R; Undas, A | 1 |
| Boinska, J; Gadomska, G; Jachalska, A; Michalska, M; Rość, D; Ślusarz, R; Stankowska, K; Tylicka, M | 1 |
| Hallert, C; Järemo, P; Lindahl, T; Lotfi, K; Milovanovic, M | 1 |
| Harper, MT; Hers, I; Hunter, RW; Moore, SF; Mumford, AD; Poole, AW; Savage, JS; Siddiq, S; Westbury, SK | 1 |
| Bareford, D; Blann, A; Caine, G | 1 |
| Duner, E; Fabris, F; Lombardi, AM; Randi, ML; Ruzzon, E; Scandellari, R; Scapin, M; Tezza, F | 1 |
| Bihour, C; Nurden, AT; Nurden, P; Raymond, JM; Smith, M | 1 |
| Kutti, J; Wadenvik, H | 1 |
| Kinoshita, S; Matsubuchi, T; Matsumiya, K; Nishimura, K; Oka, T; Takaha, M; Tsujimura, A; Yasui, M; Yasunaga, Y | 1 |
| Bassignana, A; Bazzan, M; Bertello, F; Casaccia, M; Marranca, D; Pennone, M; Pileri, A; Schinco, P; Tamponi, G | 1 |
| Baumann, B; Hehlmann, R; Hillmar, I | 1 |
| Blanco, A; Dupont, J; Fernandez, J; Lazzari, MA; Maugeri, N; Meschengieser, S; Woods, A | 1 |
| Holburn, RR; Martinez, J; Shapiro, SS | 1 |
| Klimova, KN; Shitikova, AS | 1 |
| Fernàndez-Chacón, JL; Gasalla Chacón, R; Montero García, JM; Noriega Marcos, JA; Rodríguez Lucio, E | 1 |
2 review(s) available for fibrinogen and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis.
Topics: Blood Sedimentation; Colony-Forming Units Assay; Diagnosis, Differential; Erythrocyte Volume; Fibrinogen; Humans; Hyperplasia; Interleukin-6; Megakaryocytes; Platelet Aggregation; Platelet Count; Splenomegaly; Thrombocythemia, Essential; Thrombocytosis | 1996 |
[Mechanism of hemorrhagic diathesis in acute leukemia and chronic myeloleukemia (review of the literature)].
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Cell Membrane Permeability; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Thrombocythemia, Essential; Thrombocytopenia; Thromboplastin | 1968 |
13 other study(ies) available for fibrinogen and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Altered plasma fibrin clot properties in essential thrombocythemia.
Topics: Adult; Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Case-Control Studies; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Humans; Janus Kinase 2; Male; Middle Aged; Nephelometry and Turbidimetry; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Count; Platelet Factor 4; Thrombocythemia, Essential; Thrombosis; Tissue Plasminogen Activator | 2016 |
VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms.
Topics: Aged; Blood Cell Count; Bone Marrow; DNA Mutational Analysis; Female; Fibrinogen; Fusion Proteins, bcr-abl; Humans; Male; Middle Aged; Neovascularization, Pathologic; Polycythemia Vera; Primary Myelofibrosis; Statistics, Nonparametric; Thrombocythemia, Essential; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Platelet density distribution in essential thrombocythemia.
Topics: Blood Platelets; CD40 Ligand; Fibrinogen; Flow Cytometry; Humans; Megakaryocytes; P-Selectin; Platelet Activation; Platelet Count; Thrombocythemia, Essential | 2010 |
Dysfunction of the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia.
Topics: Adult; Aged; Amino Acid Substitution; Blood Platelets; Case-Control Studies; Female; Fibrinogen; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Shelterin Complex; Signal Transduction; Telomere-Binding Proteins; Thrombin; Thrombocythemia, Essential; Thrombopoietin | 2013 |
Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count.
Topics: Aged; Biomarkers; Case-Control Studies; Cell Adhesion Molecules; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Thrombocythemia, Essential; von Willebrand Factor | 2004 |
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders.
Topics: Adult; Case-Control Studies; DNA Mutational Analysis; Factor XII; Female; Fibrinogen; Hemostasis; Humans; Integrin beta3; Janus Kinase 2; Male; Philadelphia Chromosome; Polycythemia Vera; Polymorphism, Genetic; Risk Assessment; Risk Factors; Thrombocythemia, Essential; Venous Thrombosis | 2007 |
Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Disease Susceptibility; Female; Fibrinogen; Flow Cytometry; Humans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Portal Vein; Receptors, Purinergic P2; Splenic Vein; Thrombocythemia, Essential; Thrombosis; Ticlopidine | 1996 |
[Clinical experience of urological surgery of the patients with hemostatic disorder or hemolytic disease].
Topics: Adult; Aged; Blood Coagulation Factors; Blood Transfusion, Autologous; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Hemophilia B; Humans; Hydroxyurea; Lithotripsy; Male; Middle Aged; Spherocytosis, Hereditary; Thrombocythemia, Essential; Urologic Diseases; von Willebrand Diseases; Warfarin | 1992 |
Platelet behavior in essential thrombocythemia: a study of 31 cases.
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Factor VIIa; Fibrinogen; Humans; Middle Aged; Platelet Aggregation; Platelet Factor 4; Retrospective Studies; Thrombocythemia, Essential | 1989 |
[Thrombocyte function in essential thrombocythemia and reactive thrombocytosis].
Topics: Blood Platelets; Cyclic AMP; Fibrinogen; Humans; Orosomucoid; Platelet Aggregation; Platelet Count; Platelet Function Tests; Thrombocythemia, Essential; Thrombocytosis | 1988 |
Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders.
Topics: Antigens; Blood Platelets; Fibrinogen; Humans; Leukemia, Myeloid; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Reference Values; Thrombocythemia, Essential; von Willebrand Factor | 1987 |
Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Busulfan; Fibrinogen; Hematocrit; Humans; Iodine Isotopes; Leukocytes; Middle Aged; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Prothrombin; Splenomegaly; Thrombocythemia, Essential; Thrombocytosis | 1973 |
[Hemorrhagic thrombocythemia].
Topics: Aged; Autopsy; Female; Fibrinogen; Humans; Prothrombin Time; Thrombocythemia, Essential | 1968 |